Skip to main content

Testosterone Pellets for Subcutaneous Implantation Shortage

Last Updated: December 10, 2020
Status: Resolved

Reason for the Shortage
    • Endo Pharmaceuticals did not provide a reason for the shortage.
Available Products
    • Testopel pellet, Endo Pharmaceuticals, 75 mg, for subcutaneous implantation 10 count, NDC 66887-0004-10
    • Testopel pellet, Endo Pharmaceuticals, 75 mg, for subcutaneous implantation 100 count, NDC 66887-0004-20

Estimated Resupply Dates

    • Endo Pharmaceuticals has Testopel pellets for subcutaneous implantation available.

Updated

Updated December 10, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 13, 2020 by Leslie Jensen, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer